Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|February 27, 2022
A fit-for-purpose LC-MS/MS method for the analysis of selected Streptococcal quorum sensing peptides in human salivaFrederick Verbeke, Kevin Van der Borght, Anton De Spiegeleer, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin caseNathalie Bracke, Yorick Janssens, Evelien Wynendaele, et al.
Frontiers in Immunology|July 12, 2023
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvantGwenn Waerlop, Yorick Janssens, Bart Jacobs, et al.
Plos One|November 5, 2015
Quorum Sensing Peptides Selectively Penetrate the Blood-Brain BarrierEvelien Wynendaele, Frederick Verbeke, Sofie Stalmans, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 25, 2019
Quorum sensing molecules as a novel microbial factor impacting muscle cellsAnton De Spiegeleer, Dirk Elewaut, Nele Van Den Noortgate, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2019
WITHDRAWN: This article has been withdrawnAnton De Spiegeleer, Dirk Elewaut, Nele Van Den Noortgate, et al.
BMC Microbiology|June 6, 2018
Disbiome database: linking the microbiome to diseaseYorick Janssens, Joachim Nielandt, Antoon Bronselaer, et al.
Talanta|March 5, 2018
Development of a capillary zone electrophoresis method to quantify E. colil-asparaginase and its acidic variantsHan Yao, Jana Vandenbossche, Cari E Sänger-van de Griend, et al.
The Lancet. Infectious Diseases|July 30, 2023
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trialIsabel Leroux-Roels, Paul Willems, Gwenn Waerlop, et al.
Vaccines|January 8, 2025
Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older AdultsBart Jacobs, Isabel Leroux-Roels, Jacques Bruhwyler, et al.
Pageof 3